Mostrar el registro sencillo del ítem
dc.contributor.author | Rodríguez Pérez, Isabel | |
dc.contributor.author | Gros Otero, Juan | |
dc.contributor.author | Teus Guezala, Miguel A. | |
dc.contributor.author | García González, Montserrat | |
dc.date.accessioned | 2020-01-15T19:44:24Z | |
dc.date.available | 2020-01-15T19:44:24Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Rodríguez-Pérez, I., Gros-Otero, J., Teus, M. A., Cañones, R., & García-González, M. (2019). Myopic Laser-Assisted Subepithelial Keratectomy (LASEK) outcomes using three different excimer laser platforms: A retrospective observational study. BMC Ophthalmology, 19(1), 205. https://doi.org/10.1186/s12886-019-1214-y | spa |
dc.identifier.issn | 1471-2415 | |
dc.identifier.uri | http://hdl.handle.net/11268/8516 | |
dc.description.abstract | Background: To compare the visual and refractive outcomes after myopic LASEK using three different excimer lasers and standardized surgical and mitomycin C (MMC) application protocols. Methods: In this retrospective, observational cohort study, we examined 122 eyes treated with Allegretto, 135 eyes treated with Esiris and 137 eyes treated with Technolas excimer lasers. All eyes were treated under the same surgical protocol, and a standardized MMC dosage was used. The three groups were refraction-matched, and both visual and refractive outcomes were evaluated at 1 and 7 days and 1 and 3 months after surgery. Results: At 3 months postsurgery, Allegretto provided significantly better outcomes than Esiris and Technolas in terms of postoperative uncorrected distance visual acuity (UDVA) (1.11 ± 0.2 vs 1.01 ± 0.2 vs 0.98 ± 0.2) (P = 0.0001), corrected distance visual acuity (CDVA) (1.13 ± 0.2 vs 1.10 ± 0.1 vs 1.04 ± 0.2) (P = 0.0001), residual sphere (− 0.01 ± 0.2 vs + 0.29 ± 0.7 vs + 0.27 ± 0.6) (P = 0.0001), and efficacy index (0.99 ± 0.2 vs 0.90 ± 0.2 vs 0.91 ± 0.2) (P = 0.0004). Conclusions: We found slightly better visual and refractive outcomes in the Allegretto group at 3 months post-op after LASEK with MMC to correct myopia. | spa |
dc.description.sponsorship | Sin financiación | spa |
dc.language.iso | spa | spa |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | Myopic Laser-Assisted Subepithelial Keratectomy (LASEK) outcomes using three different excimer laser platforms: A retrospective observational study | spa |
dc.type | article | spa |
dc.description.impact | 1.413 JCR (2019) Q3, 42/60 Ophthalmology | spa |
dc.description.impact | 0.759 SJR (2019) Q2, 47/124 Ophthalmology, 824/2754 Medicine (miscellaneous) | spa |
dc.description.impact | No data IDR 2019 | spa |
dc.identifier.doi | 10.1186/s12886-019-1214-y | |
dc.rights.accessRights | openAccess | spa |
dc.subject.uem | Oftalmología | spa |
dc.subject.uem | Tecnología médica | spa |
dc.subject.uem | Cirugía láser | spa |
dc.subject.unesco | Oftalmología | spa |
dc.subject.unesco | Tecnología médica | spa |
dc.subject.unesco | Rayo láser | spa |
dc.description.filiation | UEM | spa |
dc.peerreviewed | Si | spa |